Sowell Financial Services LLC Catalent, Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$100.34 - $115.69 $8,829 - $10,180	-88 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$101.51 - $125.27 $7,410 - $9,144	-73 Reduced 45.34%	88 $9,000
Q4 2020 Jan 13, 2021	BUY	$85.88 - $105.36 $3,177 - $3,898	37 Added 29.84%	161 $17,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $2,112 - $3,477	44 Added 55.0%	124 $9,000
Q1 2020 May 12, 2020	SELL	$36.95 - $62.95 $19,324 - $32,922	-523 Reduced 86.73%	80 $4,000
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $28,612 - $35,004	603 New	603 $29,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.